AI Pharmaceutical Company Galixir Completes Two Financing Rounds, Raising Tens of Millions of Dollars AI pharmaceutical company Galixir announced on Dec. 29 the completion of its latest two financing rounds, the Series A and Series A+, together worth tens of millions of dollars.
